A detailed history of Siren, L.L.C. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Siren, L.L.C. holds 5,721,172 shares of WVE stock, worth $81.6 Million. This represents 2.35% of its overall portfolio holdings.

Number of Shares
5,721,172
Holding current value
$81.6 Million
% of portfolio
2.35%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.12 - $9.01 $29.3 Million - $51.5 Million
5,721,172 New
5,721,172 $46.9 Billion

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.24B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Siren, L.L.C. Portfolio

Follow Siren, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Siren, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Siren, L.L.C. with notifications on news.